🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Megan Michta

Megan Michta

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “GLP ‐ 1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score Matching”.

GLP ‐ 1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score Matching

Liver International(2025)10.1111/liv.70447

N/A

0DataRank · unranked

4 citations

Tushar Kamath, Vy H. Nguyen, Eric M. Przybyszewski, Jiunn Song, Allison J. Carroll +5 more

Association of Sodium-Glucose Cotransporter-2 Inhibitors With Reduced Hepatocellular Carcinoma Risk in Patients With Type 2 Diabetes

The American Journal of Gastroenterology(2025)10.14309/ajg.0000000000003889

N/A

0DataRank · unranked

1 citations

Vy H. Nguyen, Eric M. Przybyszewski, Jiunn Song, Allison J. Carroll, Megan Michta +4 more

Comparative effectiveness of antidiabetic therapies on hepatic decompensation in patients with type 2 diabetes: A target trial emulation

JHEP Reports(2025)10.1016/j.jhepr.2025.101624

N/A

0DataRank · unranked

0 citations

Ana Verma, Vy H. Nguyen, Eric M. Przybyszewski, Jiunn Song, Allison J. Carroll +5 more

Comparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediate fibrosis

Clinical and Molecular Hepatology(2025)10.3350/cmh.2025.0825

N/A

0DataRank · unranked

0 citations

Daniel Fulop, Vy H. Nguyen, Eric M. Przybyszewski, Jiunn Song, Allison J. Carroll +5 more